BC
Bicara Therapeutics Inc. Common Stock (BCAX)
NASDAQ·Healthcare·Biotechnology
$8.86
+2.43%
Mkt Cap $592.91M
Analyst Ratings
Buy
5
Hold
3
Sell
1
Price Target (16 analysts)
$32.57
Range $20.00 – $42.00
Implied Upside
+267.6%
Consensus $32.57 vs current $8.86